You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

2nd line or relapsed

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in Germany (Standard chemo, Romiplostim, Placebos)

Terminated
  • Ovarian Cancer
  • Standard chemotherapy
  • +2 more
  • Berlin, Germany
  • +12 more
Feb 3, 2021

Healthcare Cost and Resource Utilization in Type 2 Diabetes and

Withdrawn
  • Diabetes Mellitus, Type 2
  • Cardiovascular Diseases
  • Ridgefield, Connecticut
    Boehringer Ingelheim Pharmaceuticals Inc
May 30, 2022

Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in Hangzhou (Sintilimab)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 2, 2020

Gastric Cancer, Gastroesophageal Junction (GEJ) Cancer Trial (T-Dxd(Trastuzmab deruxtecan), Ramucirumab)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction (GEJ) Cancer
  • T-Dxd(Trastuzmab deruxtecan), Ramucirumab
  • (no location specified)
Jun 7, 2023

Multiple Myeloma Trial in Seoul (Lenalidomide maintenance)

Recruiting
  • Multiple Myeloma
  • Lenalidomide maintenance
  • Seoul, Korea, Republic of
    Samsung Medical Center
Aug 10, 2022

Education Trial in Malatya (Experimental: 1st Experimental Group, Experimental: 2nd Experimental Group)

Not yet recruiting
  • Education
  • Experimental: 1st Experimental Group
  • Experimental: 2nd Experimental Group
  • Malatya, Turkey
    Turgut Ozal Medical Center
Nov 16, 2023

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Seoul (afatinib, paclitaxel)

Completed
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System, Yonsei Canc
Jan 26, 2023

Lazertinib as the 2nd-Line Treatment in EGFR Mutation+ NSCLC

Completed
  • Non-small Cell Lung Cancer
  • (no location specified)
May 8, 2023

Esophageal Squamous Cell Carcinoma Trial in Hangzhou (Cadonilimab combined Anlotinib)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Cadonilimab combined Anlotinib
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 6, 2023

Small Cell Lung Cancer Trial in Saint Louis (AL8326 low dose group, AL8326 middle dose group, AL8326 high dose group)

Recruiting
  • Small Cell Lung Cancer
  • AL8326 low dose group
  • +2 more
  • Saint Louis, Missouri
    Siteman cancer center, Washington University
Nov 1, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver Trial in Atlanta

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Y-90 SIR-Spheres
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 7, 2022

Non-Hodgkin Lymphoma, Large B-cell Lymphoma Trial in Palo Alto (Axicabtagene Ciloleucel)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Large B-cell Lymphoma
  • Axicabtagene Ciloleucel
  • Palo Alto, California
    Stanford University
Mar 20, 2023

A Real-world Study of Inetetamab for First-line Treatment of MBC

Not yet recruiting
  • Breast Cancer
  • Real-world Study
  • (no location specified)
Aug 6, 2023

Neuroblastoma, Osteosarcoma Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine)

Recruiting
  • Neuroblastoma
  • Osteosarcoma
  • iC9.GD2.CAR.IL-15 T-cells
  • +2 more
  • Atlanta, Georgia
  • +1 more
Jan 4, 2023

Overall Survival Trial in Qingdao (Anlotinib, PD-1 inhibitor)

Recruiting
  • Overall Survival
  • Anlotinib, PD-1 inhibitor
  • Qingdao, Shandong, China
  • +1 more
Feb 23, 2022

B-cell Non Hodgkin Lymphoma Trial in Hanzhou (CB dualCAR-NK19/70)

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • CB dualCAR-NK19/70
  • Hanzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 25, 2022

HER2-positive Gastric Cancer Trial in Seoul (Tislelizumab+Zanidatamab)

Not yet recruiting
  • HER2-positive Gastric Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Feb 25, 2022

Colorectal Cancer, Liver Metastases, Chemo Effect Trial in Oslo (Floxuridine, Liver Transplantation)

Recruiting
  • Colorectal Cancer
  • +2 more
  • Oslo, Norway
    Oslo University Hospital
Jul 5, 2021

NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Tirelizumab；Chemotherapy monotherapy
  • (no location specified)
Jul 27, 2023

Collect Pre-existing Data on Administration of Cabozantinib in

Recruiting
  • Advanced Renal Cell Carcinoma
    • Amiens, France
    • +27 more
    Dec 26, 2022

    Locally Advanced or Metastatic Renal Cell Carcinoma Trial in Worldwide (Cabozantinib)

    Active, not recruiting
    • Locally Advanced or Metastatic Renal Cell Carcinoma
    • Salzburg, Austria
    • +39 more
    Jan 18, 2023

    Pancreatic Adenocarcinoma Trial in France, United Kingdom, United States (eryaspase, Gemcitabine plus Abraxane, Irinotecan plus

    Completed
    Has Results
    • Pancreatic Adenocarcinoma
    • Scottsdale, Arizona
    • +15 more
    Sep 27, 2022

    B-cell Non-Hodgkin's Lymphoma Trial in Hangzhou (CD19-CAR-DNT cells)

    Recruiting
    • B-cell Non-Hodgkin's Lymphoma
    • CD19-CAR-DNT cells
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Jul 6, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +5 more
    • (no location specified)
    Jul 21, 2023

    Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Squamous Cell Carcinoma Trial in China (TQB2618 injection,

    Not yet recruiting
    • Recurrent Squamous Cell Carcinoma of the Head and Neck
    • Metastatic Squamous Cell Carcinoma
    • TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin or Carboplatin
    • Penpulimab injection, Paclitaxel, Cisplatin or Carboplatin
    • Lanzhou, Gansu, China
    • +11 more
    Mar 23, 2023